PNC Financial Services Group’s Karyopharm Therapeutics KPTI Stock Holding History

PNC Financial Services Group’s Portfolio KPTI Stock Details KPTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-200	Closed	-$2.49K	–	4869
2024 Q3	$2.49K	Hold	200	–	–	﹤0.01%	4239
2024 Q2	$2.6K	Hold	200	–	–	﹤0.01%	4190
2024 Q1	$4.53K	Hold	200	–	–	﹤0.01%	3982
2023 Q4	$2.6K	Hold	200	–	–	﹤0.01%	4127
2023 Q3	$4.02K	Hold	200	–	–	﹤0.01%	4046
2023 Q2	$5.37K	Hold	200	–	–	﹤0.01%	4096
2023 Q1	$11.7K	Hold	200	–	–	﹤0.01%	3747
2022 Q4	$10.2K	Hold	200	–	–	﹤0.01%	3771
2022 Q3	$16K	Hold	200	–	–	﹤0.01%	3551
2022 Q2	$14K	Sell	200 -53	-21%	-$4.86K	﹤0.01%	3652
2022 Q1	$28K	Hold	253	–	–	﹤0.01%	3415
2021 Q4	$24K	Hold	253	–	–	﹤0.01%	3464
2021 Q3	$22K	Hold	253	–	–	﹤0.01%	3462
2021 Q2	$39K	Sell	253 -881	-78%	-$128K	﹤0.01%	3194
2021 Q1	$179K	Hold	1,134	–	–	﹤0.01%	2230
2020 Q4	$263K	Buy	1,134 +881	+348%	+$204K	﹤0.01%	1893
2020 Q3	$55K	Hold	253	–	–	﹤0.01%	2683
2020 Q2	$72K	Hold	253	–	–	﹤0.01%	2546
2020 Q1	$73K	Hold	253	–	–	﹤0.01%	2411
2019 Q4	$73K	Hold	253	–	–	﹤0.01%	2672
2019 Q3	$37K	Hold	253	–	–	﹤0.01%	3068
2019 Q2	$23K	Hold	253	–	–	﹤0.01%	3300
2019 Q1	$22K	Hold	253	–	–	﹤0.01%	3322
2018 Q4	$36K	Buy	253 +220	+667%	+$37.1K	﹤0.01%	3038
2018 Q3	$9K	Hold	33	–	–	﹤0.01%	3696
2018 Q2	$8K	Hold	33	–	–	﹤0.01%	3747
2018 Q1	$7K	Buy	+33	New	+$6.58K	﹤0.01%	3826

Other funds holding KPTI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

CCM

Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

PNC Financial Services Group's KPTI Position: Q4 2024 in Review

PNC Financial Services Group sold out of Karyopharm Therapeutics (KPTI) in Q4 2024, closing a stake of 200 shares — an estimated $2.49K sold.

PNC Financial Services Group first reported a position in KPTI in Q1 2018 and held it in 27 quarters. The position peaked at $263K in Q4 2020. 87 funds tracked by Wall St. Rank hold KPTI as of Q4 2024.

PNC Financial Services Group reported no remaining Karyopharm Therapeutics position as of Q4 2024 after selling out during the quarter.
PNC Financial Services Group sold 200 Karyopharm Therapeutics shares in Q4 2024, an estimated $2.49K.
PNC Financial Services Group first reported a position in Karyopharm Therapeutics in Q1 2018 and held it in 27 quarters.
PNC Financial Services Group's Karyopharm Therapeutics position peaked at $263K in Q4 2020.
87 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q4 2024.

Based on PNC Financial Services Group's 13F filing for Q4 2024, filed 7 Feb 2025.